What does Apotheek Saint-Germain do?

Apotheek Saint-Germain is a pharmacy in Ieper. Public Limited, started on 26 September 1990, 1 establishment.

What is the address of Apotheek Saint-Germain?

The registered office of Apotheek Saint-Germain is located at Rijselstraat 43, 8900 Ieper.

Is Apotheek Saint-Germain still active?

Yes. According to the CBE (29 October 2026) Apotheek Saint-Germain is active, legal situation “Normale toestand”, started on 26 September 1990.

Is Apotheek Saint-Germain registered on Peppol?

Yes, Apotheek Saint-Germain is registered on the Peppol network with ID 0208:0441662675.

What is the enterprise number of Apotheek Saint-Germain?

The enterprise number of Apotheek Saint-Germain is BE0441662675.

When was Apotheek Saint-Germain founded?

Apotheek Saint-Germain was founded on 26 September 1990.

Who are the directors of Apotheek Saint-Germain?

According to the 2025 annual accounts, the directors of Apotheek Saint-Germain are: ASG Pharma Invest BV.

Is Apotheek Saint-Germain a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 September 1990; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Saint-Germain make in 2025?

Apotheek Saint-Germain posted a profit after taxes of € 44,696 in financial year 2025.

What is the revenue of Apotheek Saint-Germain?

As a small company, Apotheek Saint-Germain is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 127,398.

How much does an employee at Apotheek Saint-Germain earn?

The average wage cost per full-time employee at Apotheek Saint-Germain was € 33,300 in 2025: staff costs of € 53,231 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Saint-Germain have?

According to the 2025 annual accounts, Apotheek Saint-Germain has 1.6 full-time equivalents (FTE).

Apotheek Saint-Germain (Public Limited) - Ieper

Dossier Apotheek Saint-Germain, printed on 29 October 2026 from databakkes.be/en/0441662675/apotheek-saint-germain. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Saint-Germain from Ieper, company number BE0441662675, closed financial year 2025 with a result of € 44,696 after tax. For that financial year Apotheek Saint-Germain recorded a gross margin of € 127,398 and equity of € 178,558. Compared with financial year 2024, the result moved from € 559 to € 44,696. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 8, 2026.

What it is worth Growing

€ 178,558

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 44,696

▲ € 44,137 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 192

▼ € 102,078 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 44,000 paid out

98 % of the profit went to the shareholders, mostly to ASG Pharma Invest (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.6

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 53,231

▲ 34% vs 2024

€ 33,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 49,535

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 91,666

▼ 23% vs 2024

€ 27,500 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 7,421

▼ 89% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,877

▲ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 228,636 Gross margin 2022: € 228,636 First fiscal year in the series	€ 194,777 Gross margin 2023: € 194,777 ▼ 15% vs 2022 (€ 228,636) Unfavourable step	€ 79,778 Gross margin 2024: € 79,778 ▼ 59% vs 2023 (€ 194,777) Unfavourable step	€ 127,398 Gross margin 2025: € 127,398 ▲ 60% vs 2024 (€ 79,778) Favourable step	▲ 60%
Profit after taxes	€ 35,439 Profit after taxes 2022: € 35,439 First fiscal year in the series	€ 15,024 Profit after taxes 2023: € 15,024 ▼ 58% vs 2022 (€ 35,439) Unfavourable step	€ 559 Profit after taxes 2024: € 559 ▼ 96% vs 2023 (€ 15,024) Unfavourable step	€ 44,696 Profit after taxes 2025: € 44,696 ▲ € 44,137 vs 2024 (€ 559) Favourable step	▲ € 44,137
Equity	€ 162,278 Equity 2022: € 162,278 First fiscal year in the series	€ 177,302 Equity 2023: € 177,302 ▲ 9% vs 2022 (€ 162,278) Favourable step	€ 177,862 Equity 2024: € 177,862 Unchanged (€ 177,302) Favourable step	€ 178,558 Equity 2025: € 178,558 Unchanged (€ 177,862) Favourable step
Total debts	€ 316,899 Total debts 2022: € 316,899 First fiscal year in the series	€ 236,134 Total debts 2023: € 236,134 ▼ 25% vs 2022 (€ 316,899) Favourable step	€ 197,004 Total debts 2024: € 197,004 ▼ 17% vs 2023 (€ 236,134) Favourable step	€ 156,965 Total debts 2025: € 156,965 ▼ 20% vs 2024 (€ 197,004) Favourable step	▼ 20%
Cash	€ 145,533 Cash 2022: € 145,533 First fiscal year in the series	€ 119,766 Cash 2023: € 119,766 ▼ 18% vs 2022 (€ 145,533) Unfavourable step	€ 102,270 Cash 2024: € 102,270 ▼ 15% vs 2023 (€ 119,766) Unfavourable step	€ 192 Cash 2025: € 192 ▼ € 102,078 vs 2024 (€ 102,270) Unfavourable step	▼ € 102,078
Retained profit	€ 100,278 Retained profit 2022: € 100,278 First fiscal year in the series	€ 115,302 Retained profit 2023: € 115,302 ▲ 15% vs 2022 (€ 100,278) Favourable step	€ 115,862 Retained profit 2024: € 115,862 Unchanged (€ 115,302) Favourable step	€ 116,558 Retained profit 2025: € 116,558 ▲ 1% vs 2024 (€ 115,862) Favourable step	▲ 1%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 44,000 Dividend 2025: € 44,000 Unchanged (€ 0) Unchanged
Bank debt	€ 174,167 Bank debt 2022: € 174,167 First fiscal year in the series	€ 146,666 Bank debt 2023: € 146,666 ▼ 16% vs 2022 (€ 174,167) Favourable step	€ 119,166 Bank debt 2024: € 119,166 ▼ 19% vs 2023 (€ 146,666) Favourable step	€ 91,666 Bank debt 2025: € 91,666 ▼ 23% vs 2024 (€ 119,166) Favourable step	▼ 23%
Balance sheet total	€ 479,177 Balance sheet total 2022: € 479,177 First fiscal year in the series	€ 413,436 Balance sheet total 2023: € 413,436 ▼ 14% vs 2022 (€ 479,177) Unchanged	€ 374,865 Balance sheet total 2024: € 374,865 ▼ 9% vs 2023 (€ 413,436) Unchanged	€ 335,523 Balance sheet total 2025: € 335,523 ▼ 10% vs 2024 (€ 374,865) Unchanged	▼ 10%
Employees (FTE)	3 Employees (FTE) 2022: 3 First fiscal year in the series	2.4 Employees (FTE) 2023: 2.4 ▼ 0.6 vs 2022 (3) Unchanged	1 Employees (FTE) 2024: 1 ▼ 1.4 vs 2023 (2.4) Unchanged	1.6 Employees (FTE) 2025: 1.6 ▲ 0.6 vs 2024 (1) Unchanged	▲ 0.6

Key figures of Apotheek Saint-Germain, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Saint-Germain?

What happened at Apotheek Saint-Germain in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 8, 2026 New annual accounts for financial year 2025: profit of € 44,696 (▲ € 44,137 vs 2024). Source: NBB ↗
Oct 24, 1990 New establishment in Ieper. KBO
Sep 26, 1990 Start of the company according to the CBE. KBO

In short

From € 35,439 profit in 2022 to € 44,696 profit in 2025.

Paid € 2,106 in corporate taxes since 2022.

Best year ever: 2025, with € 44,696 profit.

On average € 79,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ASG Pharma Invest 100%

The stake of ASG Pharma Invest comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Saint-Germain

Behind Apotheek Saint-Germain is ASG Pharma Invest BV. The shares are held by ASG Pharma Invest (100%).

Directors

According to the 2025 annual accounts

ASG Pharma Invest BV

Director · represented by Jonas Degroote

Also active at: DE FRENCH

Shareholders

ASG Pharma Invest

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rijselstraat 43

8900 Ieper

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0441.662.675

VAT number

BE 0441.662.675

Registered office

Rijselstraat 43, 8900 Ieper

Names & denominations

Apotheek Saint-Germain

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

26 September 1990

Peppol

Active · Active since 20 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Saint-Germain

Financials

What happened to Apotheek Saint-Germain?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions